Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis

Journal of Dermatological Science

Volumn 72, Issue 3, 2013, Pages 311-319

  Zhu, Li ^a,b   Kohda, Futoshi ^a   Nakahara, Takeshi ^a   Chiba, Takahito ^a   Tsuji, Gaku ^a   Hachisuka, Junichi ^a   Ito, Takamichi ^a   Tu, Yating ^b   Moroi, Yoichi ^a   Uchi, Hiroshi ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ca2+ binding S 100 proteins; Epidermal tumors; Immunohistochemistry; Matrix metalloproteinases 9

Indexed keywords

CALCIUM BINDING PROTEIN; CALCYCLIN; GELATINASE B; PROTEIN A100A2; PROTEIN A100A4; PSORIASIN; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATOACANTHOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; UPREGULATION;

CA2(+)-BINDING S-100 PROTEINS; EPIDERMAL TUMORS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES 9;

CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; EPIDERMIS; HUMANS; MATRIX METALLOPROTEINASE 9; RETROSPECTIVE STUDIES; S100 PROTEINS; SKIN NEOPLASMS;

EID: 84887204421     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.07.005     Document Type: Article

References (58)

1. Fullen D.R., Garrisi A.J., Sanders D., Thomas D. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays. J Cutan Pathol 2008, 35:28-34.
2. Yáñez M., Gil-Longo J., Campos-Toimil M. Calcium binding proteins. Adv Exp Med Biol 2012, 740:461-482.
3. Yao R., Lopez-Beltran A., Maclennan G.T., Montironi R., Eble J.N., Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007, 27:3051-3058.
4. Lee K., Yun S.T., Yun C.O., Ahn B.Y., Jo E.C. S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma. Gene Ther 2012, 19:967-977.
5. Sekine H., Chen N., Sato K., Saiki K., Yoshiono Y., Umetsu Y., et al. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Biochem Biophys Res Commun 2012, 429:214-219.
6. Calabretta B., Battini R., Kaczmarek L., de Riel J.K., Baserga R. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J Biol Chem 1986, 261:12628-12632.
7. Kilańczyk E., Graczyk A., Ostrowska H., Kasacka I., Leśniak W., Filipek A. S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells. Cell Calcium 2012, 51:470-477.
8. Ning X., Sun S., Zhang K., Liang J., Chuai Y., Li Y., et al. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis. PLoS ONE 2012, 7:e30185.
9. Yang X., Wei K.J., Zhang L., Pan H.Y., Ye D.X., Zhong L.P., et al. Decreased expression of S100A6 in oral squamous cell carcinoma. Oncol Rep 2010, 24:479-488.
10. Celis J.E., Crüger D., Kiil J., Deigaard K., Lauridsen J.B., Ratz G.P., et al. A two-dimensional gel protein database of noncultured total normal human epidermal keratinocytes: identification of proteins strongly up-regulated in psoriatic epidermis. Electrophoresis 1990, 11:242-254.
11. Gläser R., Köten B., Wittersheim M., Harder J. Psoriasin: key molecule of the cutaneous barrier. J Dtsch Dermatol Ges 2011, 9:897-902.
12. Winston J., Psoriasin Wolf R. (S100A7) promotes migration of a squamous carcinoma cell line. J Dermatol Sci 2012, 67:205-207.
13. Nasser M.W., Qamri Z., Deol Y.S., Ravi J., Powell C.A., Trikha P., et al. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 2012, 72:604-615.
14. Cui J.F., Liu Y.K., Zhang L.J., Shen H.L., Song H.Y., Dai Z., et al. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics 2006, 6:5953-5961.
15. Roh S.A., Choi E.Y., Cho D.H., Jang S.J., Kim S.Y., Kim Y.S., et al. Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change. J Korean Med Sci 2010, 25:353-360.
16. Mishra S.K., Siddique H.R., Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 2012, 31:163-172.
17. Yammani R.R. S100 proteins in cartilage: role in arthritis. Biochim Biophys Acta 2012, 1822:600-606.
18. Zhang T., Woods T.L., Elder J.T. Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes. J Invest Dermatol 2002, 119:1196-1201.
19. Wolf S., Haase-Kohn C., Pietzsch J. S100A2 in cancerogenesis: a friend or a foe. Amino Acids 2011, 41:849-861.
20. Jiang H., Hu H., Tong X., Jiang Q., Zhu H., Zhang S. Calcium-binding protein S100P and cancer: mechanisms and clinical relevance. J Cancer Res Clin Oncol 2012, 138:1-9.
21. Ehrchen J.M., Sunderkotter C., Foell D., Vogl T., Roth J. The endogenous toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009, 86:557-566.
22. Salama I., Malone P.S., Mihaimeed F., Jones J.L. A review of the S100 proteins in cancer. Eur J Surg Oncol 2008, 34:357-364.
23. Chivu Economescu M., Necula L.G., Dragu D., Badea L., Dima S.O., Tudor S., et al. Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. Hepatogastroenterology 2010, 57:1453-1464.
24. Jamieson N.B., Carter C.R., McKay C.J., Oien K.A. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clin Cancer Res 2011, 17:3316-3331.
25. Ohuchida K., Mizumoto K., Miyasaka Y., Yu J., Cui L., Yamaguchi H., et al. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. J Pathol 2007, 213:275-282.
26. Kwon Y.W., Chang I.H., Kim K.D., Kim Y.S., Myung S.C., Kim M.K., et al. Significance of S100A2 and S100A4 expression in the progression of prostate adenocarcinoma. Korean J Urol 2010, 51:456-462.
27. Luo J., Zhu Y., Yang G., Gong L., Wang B., Liu H. Loss of reprimo and S100A2 expression in human gastric adenocarcinoma. Diagn Cytopathol 2011, 39:752-757.
28. Li Y., Gudjonsson J.E., Woods T.L., Zhang T., Johnston A., Stoll S.W., et al. Transgenic expression of S100A2 in hairless mouse skin enhances Cxcl13 mRNA in response to solar-simulated radiation. Arch Dermatol Res 2009, 301:205-217.
29. Shrestha P., Muramatsu Y., Kudeken W., Mori M., Takai Y., Schafer B.W., et al. Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin. Virchows Arch 1998, 432:53-59.
30. Park H.R., Min S.K. Expression of S100A2 and S100B proteins in epithelial tumors of the skin. J Cutan Pathol 2003, 30:373-378.
31. Zhu L., Okano S., Takahara M., Chiba T., Tu Y., Oda Y., et al. Expression of S100 protein family members in normal skin and sweat gland tumors. J Dermatol Sci 2013, 70:211-219.
32. Yang H., Zhao K., Yu Q., Wang X., Song Y., Li R. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. J Int Med Res 2012, 40:475-485.
33. Chai J., Jamal M.M. S100A4 in esophageal cancer: is this the one to blame. World J Gastroenterol 2012, 18:3931-3935.
34. Boni R., Burg G., Doguoglu A., Ilg E.C., Schäfer B.W., Müller B., et al. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol 1997, 137:39-43.
35. Li Y., Liu Z.L., Zhang K.L., Chen X.Y., Kong Q.Y., Wu M.L., et al. Methylation-associated silencing of S100A4 expression in human epidermal cancers. Exp Dermatol 2009, 18:842-848.
36. Boomershine C.S., Chamberlain A., Kendall P., Afshar-Sharif A.R., Huang H., Washington M.K., et al. Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut 2009, 58:1267-1274.
37. Petersson S., Shubbar E., Enerback L., Enerback C. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Melanoma Res 2009, 19:215-225.
38. Liu J., Li X., Dong G.L., Zhang H.W., Chen D.L., Du J.J., et al. In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer 2008, 8:261.
39. Tripathi S.C., Matta A., Kaur J., Grigull J., Chauhan S.S., Thakar A., et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS ONE 2010, 5:e11939.
40. Winter J., Pantelis A., Reich R., Jepsen S., Allam J.P., Novak N., et al. Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression. Cancer Invest 2011, 29:478-484.
41. Emberley E.D., Murphy L.C., Watson P.H. S100A7 and the progression of breast cancer. Breast Cancer Res 2004, 6:153-159.
42. Rhee D.K., Park S.H., Jang Y.K. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model. Genomics 2008, 92:419-428.
43. Wolf R., Ruzicka T., Yuspa S.H. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Amino Acids 2011, 41:789-796.
44. Martinsson H., Yhr M., Enerback C. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 2005, 14:161-168.
45. Alowami S., Qing G., Emberley E., Snell L., Watson P.H. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol 2003, 3:1.
46. Moubayed N., Weichenthal M., Harder J., Wandel E., Sticherling M., Glaser R. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007, 133:253-261.
47. Cross S.S., Hamdy F.C., Deloulme J.C., Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-269.
48. McKiernan E., McDermott E.W., Evoy D., Crown J., Duffy M.J. The role of S100 genes in breast cancer progression. Tumour Biol 2011, 32:441-450.
49. Wang X.H., Zhang L.H., Zhong X.Y., Xing X.F., Liu Y.Q., Niu Z.J., et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. Am J Pathol 2010, 177:586-597.
50. Sapkota D., Bruland O., Boe O.E., Bakeer H., Elgindi O.A., Vasstrand E.N., et al. Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med 2008, 37:607-615.
51. Tyagi S., George J., Singh R., Bhui K., Shukla Y. Neoplastic alterations induced in mammalian skin following mancozeb exposure using in vivo and in vitro models. OMICS 2011, 15:155-167.
52. Liu Z., Li L., Yang Z., Luo W., Li X., Yang H., et al. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer 2010, 10:270.
53. Li H.C., Cao D.C., Liu Y., Hou Y.F., Wu J., Lu J.S., et al. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res Treat 2004, 88:75-85.
54. Wang B.Q., Zhang C.M., Gao W., Wang X.F., Zhang H.L., Yang P.C. Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance. J Cancer Res Clin Oncol 2011, 137:1525-1533.
55. Ye L., Sun P.H., Martin T.A., Sanders A.J., Mason M.D., Jiang W.G. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urol Oncol 2012, [Epub ahead of print].
56. Pazzaglia L., Ponticelli F., Magagnoli G., Magagnoli G., Gamberi G., Ragazzini P., et al. Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness. Anticancer Res 2004, 24(2B):967-972.
57. Wang L., Wang X., Liang Y., Diao X., Chen Q. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Acta Biochim Pol 2012, 59:593-598.
58. Jia W., Gao X.J., Zhang Z.D., Yang Z.X., Zhang G. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Eur Rev Med Pharmacol Sci 2013, 17:1495-1508.